False
About Jesús M. Paramio
Jesús is head of the Molecular Oncology Unit at CIEMAT and head of Cell and Molecular Oncology and Genitourinary Tumors at University Hospital 12 de Octubre in Madrid. His research connects epigenetics and immunotherapy in the context of metastatic bladder cancer and has provided new potential biomarkers of sensitivity to immune checkpoint blockade therapy. “Future advances in cancer treatment might make more patients susceptible to immunotherapies and open new opportunities for people with otherwise incurable neoplasias,” predicts Jesús.
Explore More in Pathology
Dive deeper into the world of pathology. Explore the latest articles, case studies, expert insights, and groundbreaking research.
Newsletters
Receive the latest pathology news, personalities, education, and career development – weekly to your inbox.
False